Giorgio De Stefano
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correlation Between the Hepatic Expression of Human MicroRNA hsa-miR-125a-5p and the Progression of Fibrosis in Patients With Overt and Occult HBV Infection.
Journal: Frontiers in immunology
Published: March 22, 2018
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Journal: Journal of gastroenterology and hepatology
Published: July 13, 2017
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.
Journal: Antiviral therapy
Published: January 30, 2017
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Journal: Oncotarget
Published: November 08, 2016
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib.
Journal: Oncotarget
Published: June 21, 2016
The role of CEUS in characterization of superficial lymph nodes: a single center prospective study.
Journal: Oncotarget
Published: March 16, 2016
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.
Journal: World journal of hepatology
Published: February 23, 2016
Synchronous and metachronous gastric gist with pancreatic adenocarcinoma: report of 2 cases and a review of literature.
Journal: Gastroenterology and hepatology from bed to bench
Published: October 16, 2015
Sorafenib after RFA in HCC patients: a pilot study.
Journal: Hepato-gastroenterology
Published: April 29, 2015
Sorafenib off-target effects predict outcomes in patients treated for hepatocellular carcinoma.
Journal: Future oncology (London, England)
Published: March 12, 2015
Efficacy of lifestyle changes in subjects with non-alcoholic liver steatosis and metabolic syndrome may be improved with an antioxidant nutraceutical: a controlled clinical study.
Journal: Drugs in R&D
Published: March 04, 2015
Last Updated: 09/26/2026